Florey Neuroscience Institutes
Overview
Florey Neuroscience Institutes (FNI) is the largest brain research group in the Southern Hemisphere. With more than 500 research and support staff on two campuses, FNI scientists are searching for cures to the complex, debilitating and sometimes life threatening brain disorders that affect three million Australians.
Through our clinical and basic research facilities in Parkville and Heidelberg, Victoria, we are investigating Parkinson’s, Huntington’s and motor neuron disease. We are world leaders in stroke and epilepsy research and have exceptional teams working on multiple sclerosis, addiction and traumatic brain and spinal cord injury among others.
Partners
Number of employees: 500
Main business focus/
Listing by sector:
- Research Organisation
- Neurology
- Regenerative & Stem Cells
- Multiple Sclerosis
- Clinical Trials
Competitive Advantages
Already a globally recognised contributor in neuroscience, the FNI positions Australia as an international front-runner in neurosciences, from discovery through to delivery. While FNI is Melbourne based, it will provide the foundation for a National Centre of Excellence, addressing big issues with global outputs and benefits such as:
- Integration of technology platforms and assembled expertise
- Ability to undertake key major global projects
- Expansion of our capability base and data analysis facilities
- Reduction in the doubling up of time and resources for discovery
- Improvement of health-care practice and information flow in aging, neurological and psychological diseases and disorders
Technology/IP
Major projects in the following key areas of neuroscience and related areas:
- Stroke
- Epilepsy
- Dementia
- Multiple Sclerosis
- Huntington’s disease
- Motor neuron disease
- Traumatic brain and spinal cord injury
- Depression
- Parkinson’s disease
- Schizophrenia
- Addiction
- Brain function in health and disase
- Neuroimaging
- Discovery research
Corporate Alliances/Partnerships
- Corthera
- Schering AG
- Circadian Technologies
- Servier
- Johnson and Johnson PRD
- Merck Sharpe& Dohme
- Siemens
Partnering Opportunities
Commercial and health areas of interest leading towards discovery, development and delivery, include: stroke, nerve trauma, learning and memory, Parkinson’s disease, multiple sclerosis, epilepsy, anxiety, depression and schizophrenia.
Partnering Needs
Early stage partnering for discovery programs in the neurosciences.
Contact Details
| Contact person | Dr. Henry De Aizpurua |
|---|---|
| Job Title | Deputy Director |
| Address | Florey Neuroscience Institutes |
| Gate 11, Royal Parade | |
| City/Suburb | Parkville |
| State | Victoria |
| h.deaizpurua@florey.edu.au | |
| Phone | +61 3 8344 1808 |
| Fax | +61 3 9347 0446 |
| Website | http://www.fni.edu.au |
